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ABSTRACT 
 
 
Background 
Locally Advanced Breast Cancer (LABC) is a heterogeneous clinical entity which 
accounts for about 40% - 70% of presentation of breast cancers in the developing 
countries whereas it is about 10%-20% of the total cases in developed countries. This 
highlights the need for proper systematic screening for detection of the breast cancer. 
The profile of Age, duration of tumour, staging, Histological type and ER/PR status in 
Locally Advanced Breast Cancer is studied and presented in this study. 
 
Objectives 
The profile of Age, duration of tumour, staging, Histological type and ER/PR status in 
Locally Advanced Breast Cancer is studied and relationship between these parameters 
is calculated and presented in this study. 
 
Methodology 
Patients diagnosed as Locally Advanced Breast Cancer in department of General 
Surgery, Govt. Royapettah Hospital. 50 of them are to be selected on the basis of non 
probability (purposive) sampling method. Detailed history is elicited from the patient. 
Thorough Clinical Examination of the patient is done and disease staged according to 
TNM classification. Histopathological study of the tumor is done. The profile of Age, 
duration of tumour, staging, Histological type and ER/PR status in  Locally Advanced 
Breast Cancer is studied.  
 
 Results 
 
There was a significant statistical association between ER/PR expression with 
tumour size(p=0.01). Expression of ER/PR expression was low tumour size less than 2 
cms (100%). It was also higher in lower tumour grade. The major histological subtype 
was Infiltrating duct carcinoma, NOS type. Meanwhile there was no significant 
association of ER/PR expression with menopausal status, and other parameters. 
 
Conclusion 
 
 
Our study data indicates that ER/PR is a  predictor for good prognosis as its 
expression is associated with important prognostic parameters like decreased tumour 
size, low tumour grade. 
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